Literature DB >> 2844580

Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).

J D Berman1, M Grogl.   

Abstract

The chemical properties of the primary antileishmanial agent sodium stibogluconate (Pentostam), and the interaction of Pentostam with Leishmania mexicana amastigotes, have been investigated with the aid of [125Sb]Pentostam. The molecular weight by P2 chromatography showed [125Sb]Pentostam to be of multiple species of MW = 100-4000 Da, rather than the one species of 746 Da predicted by the commonly hypothesized structural formula. Nonradioactive Pentostam had a lower osmolarity (789 mOsm for a 100 mg Sb/ml solution) than predicted (1644 mOsm), which indicates that the multiple components of Pentostam (Sb and derivatives of gluconic acid) are more closely complexed with each other than previously thought. When incubated with L. mexicana amastigotes, labeled drug was bound to at least six polypeptides of molecular weights ranging from 14,000 to 68,000 Da as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Interaction with the polypeptides is presumed to contribute to the antileishmanial action of Pentostam.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844580     DOI: 10.1016/0014-4894(88)90012-4

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

1.  Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime).

Authors:  W L Roberts; W J McMurray; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae.

Authors:  S Dey; M Ouellette; J Lightbody; B Papadopoulou; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.

Authors:  Traci Galbaugh; Yvonne B Feeney; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2010-09-08       Impact factor: 5.852

4.  Antileishmanial activity of sodium stibogluconate fractions.

Authors:  W L Roberts; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.

Authors:  W L Roberts; J D Berman; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.

Authors:  J D Berman; G Ksionski; W L Chapman; V B Waits; W L Hanson
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

7.  Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.

Authors:  A Haimeur; M Ouellette
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

8.  Glucantime susceptibility of Leishmania promastigotes under variable growth conditions.

Authors:  E S Moreira; R M Soares; M de L Petrillo-Peixoto
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

9.  Use of antimony in the treatment of leishmaniasis: current status and future directions.

Authors:  Arun Kumar Haldar; Pradip Sen; Syamal Roy
Journal:  Mol Biol Int       Date:  2011-06-08

10.  Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.

Authors:  Taolin Yi; Paul Elson; Masato Mitsuhashi; Barbara Jacobs; Emese Hollovary; Thomas G Budd; Timothy Spiro; Pierre Triozzi; Ernest C Borden
Journal:  Oncotarget       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.